A consortium of four academic screening platforms within the European Research Infrastructure Consortium EU-OPENSCREEN have released their first open-source Cell Painting dataset, marking a major step…
Register now and meet us in Paris this year. The European Chemical Biology Symposium (ECBS) is our flagship event and brings together Chemical Biologists from all parts of Europe and overseas to…
EU-OPENSCREEN's three new partner sites presented their advanced capabilities in chemoproteomics and spatial mass spectrometry (MS)-based omics in a dedicated session at this year's Helmholtz Drug…
We are delighted to share our latest publication in SLAS Discovery, titled “Empowering Research in Chemical Biology and Early Drug Discovery – An Update from the European Research Infrastructure…
In our latest interview, EU-OPENSCREEN Director General Philip Gribbon talks about his new role as SLAS President, the future of drug discovery, and why collaboration and AI are key to driving…
An African and European research consortium receives €1.5 million from the European Union and additional resources from the Swiss government to support the accumulation of knowledge, skills and…
EU-OPENSCREEN held its biannual Assembly of Members (AoM) meeting for the first time outside of Germany. The meeting in Riga, Latvia, kicks off a new initiative to host future meetings in different…
Together with our partner sites, we encourage researchers working on the neuroscience of pain to build transnational consortia with us and apply for the ERA-Net NEURON Joint Transnational Call 2025.
The EU-OPENSCREEN team is excited to highlight that this week's SLAS conference in San Diego, California, will see Phil Gribbon becoming the SLAS President for 2025. The SLAS is the largest…
